PharmaCyte Biotech Inc (PMCB)

[BioNewton]

We all know that Fast-track really takes care of both issues. The EMA will also fast-track after the FDA does. The FDA is the leading approval agency in the world. Instead of scare tactics of a patent that expires 8 months from now, we wait to file the IND application. After that approval, none of those things matter. ODD gives us 7 years of exclusivity on its own.